These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 27496857)

  • 1. Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans.
    van der Valk FM; Bekkering S; Kroon J; Yeang C; Van den Bossche J; van Buul JD; Ravandi A; Nederveen AJ; Verberne HJ; Scipione C; Nieuwdorp M; Joosten LA; Netea MG; Koschinsky ML; Witztum JL; Tsimikas S; Riksen NP; Stroes ES
    Circulation; 2016 Aug; 134(8):611-24. PubMed ID: 27496857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a).
    Krychtiuk KA; Kastl SP; Hofbauer SL; Wonnerth A; Goliasch G; Ozsvar-Kozma M; Katsaros KM; Maurer G; Huber K; Dostal E; Binder CJ; Pfaffenberger S; Oravec S; Wojta J; Speidl WS
    J Clin Lipidol; 2015; 9(4):533-41. PubMed ID: 26228671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a).
    Tsimikas S; Duff GW; Berger PB; Rogus J; Huttner K; Clopton P; Brilakis E; Kornman KS; Witztum JL
    J Am Coll Cardiol; 2014 May; 63(17):1724-34. PubMed ID: 24530664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
    Tsimikas S; Kiechl S; Willeit J; Mayr M; Miller ER; Kronenberg F; Xu Q; Bergmark C; Weger S; Oberhollenzer F; Witztum JL
    J Am Coll Cardiol; 2006 Jun; 47(11):2219-28. PubMed ID: 16750687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation.
    Schnitzler JG; Hoogeveen RM; Ali L; Prange KHM; Waissi F; van Weeghel M; Bachmann JC; Versloot M; Borrelli MJ; Yeang C; De Kleijn DPV; Houtkooper RH; Koschinsky ML; de Winther MPJ; Groen AK; Witztum JL; Tsimikas S; Stroes ESG; Kroon J
    Circ Res; 2020 May; 126(10):1346-1359. PubMed ID: 32160811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis.
    Zheng KH; Tsimikas S; Pawade T; Kroon J; Jenkins WSA; Doris MK; White AC; Timmers NKLM; Hjortnaes J; Rogers MA; Aikawa E; Arsenault BJ; Witztum JL; Newby DE; Koschinsky ML; Fayad ZA; Stroes ESG; Boekholdt SM; Dweck MR
    J Am Coll Cardiol; 2019 May; 73(17):2150-2162. PubMed ID: 31047003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diacylglycerols and Lysophosphatidic Acid, Enriched on Lipoprotein(a), Contribute to Monocyte Inflammation.
    Dzobo KE; Cupido AJ; Mol BM; Stiekema LCA; Versloot M; Winkelmeijer M; Peter J; Pennekamp AM; Havik SR; Vaz FM; van Weeghel M; Prange KHM; Levels JHM; de Winther MPJ; Tsimikas S; Groen AK; Stroes ESG; de Kleijn DPV; Kroon J
    Arterioscler Thromb Vasc Biol; 2024 Mar; 44(3):720-740. PubMed ID: 38269588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a).
    Yeang C; Hung MY; Byun YS; Clopton P; Yang X; Witztum JL; Tsimikas S
    J Clin Lipidol; 2016; 10(3):594-603. PubMed ID: 27206947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma.
    Bergmark C; Dewan A; Orsoni A; Merki E; Miller ER; Shin MJ; Binder CJ; Hörkkö S; Krauss RM; Chapman MJ; Witztum JL; Tsimikas S
    J Lipid Res; 2008 Oct; 49(10):2230-9. PubMed ID: 18594118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease.
    Tsimikas S; Tsironis LD; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2094-9. PubMed ID: 17626905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between lipoprotein(a), oxidized phospholipids, and extracoronary vascular disease.
    Bellomo TR; Liu Y; Gilliland TC; Miksenas H; Haidermota S; Wong M; Hu X; Cristino JR; Browne A; Plutzky J; Tsimikas S; Januzzi JL; Natarajan P
    J Lipid Res; 2024 Jul; 65(7):100585. PubMed ID: 38942114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
    Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
    Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice.
    Merki E; Graham MJ; Mullick AE; Miller ER; Crooke RM; Pitas RE; Witztum JL; Tsimikas S
    Circulation; 2008 Aug; 118(7):743-53. PubMed ID: 18663084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heritability of Biomarkers of Oxidized Lipoproteins: Twin Pair Study.
    Rao F; Schork AJ; Maihofer AX; Nievergelt CM; Marcovina SM; Miller ER; Witztum JL; O'Connor DT; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1704-11. PubMed ID: 25953646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidized phospholipid modification of lipoprotein(a): Epidemiology, biochemistry and pathophysiology.
    Koschinsky ML; Boffa MB
    Atherosclerosis; 2022 May; 349():92-100. PubMed ID: 35606081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized phospholipids in cardiovascular disease.
    Tsimikas S; Witztum JL
    Nat Rev Cardiol; 2024 Mar; 21(3):170-191. PubMed ID: 37848630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
    Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
    J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study.
    Bernelot Moens SJ; van der Valk FM; Strang AC; Kroon J; Smits LP; Kneepkens EL; Verberne HJ; van Buul JD; Nurmohamed MT; Stroes ES
    Arthritis Res Ther; 2016 May; 18(1):115. PubMed ID: 27209093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.